(Q46035991)

18 December 2017

title

High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients. (English)

1 reference

18 December 2017

author name string

Guillaume Jean

1

1 reference

18 December 2017

Jean-Claude Terrat

2

1 reference

18 December 2017

Thierry Vanel

3

1 reference

18 December 2017

Jean-Marc Hurot

4

1 reference

18 December 2017

Christie Lorriaux

5

1 reference

18 December 2017

Brice Mayor

6

1 reference

18 December 2017

Charles Chazot

7

1 reference

18 December 2017

language of work or name

English

0 references

publication date

25 April 2009

1 reference

18 December 2017

Nephrology Dialysis Transplantation

published in

1 reference

18 December 2017

volume

24

1 reference

18 December 2017

page(s)

2792-2796

1 reference

18 December 2017

issue

9

1 reference

18 December 2017

Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP191

Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP191

Klotho converts canonical FGF receptor into a specific receptor for FGF23

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP191

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP191

Klotho: an antiaging protein involved in mineral and vitamin D metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP191

Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP191

Sevelamer hydrochloride and calcium bicarbonate reduce serum fibroblast growth factor 23 levels in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP191

Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP191

Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP191

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP191

Bone mass does not correlate with the serum fibroblast growth factor 23 in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP191

Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP191

Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP191

Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP191

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP191

21 January 2018

Identifiers

DOI

10.1093/NDT/GFP191

1 reference

18 December 2017

PubMed ID

19395730

1 reference

18 December 2017